Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Some mathematical statements feel so intuitive that they seem beyond doubt. Yet in certain cases, proving them has resisted decades — or even centuries — of effort. The gap between intuition and ...

The end-game of The First Descendant thrives largely on its Void Intercept Battles. Throughout the main campaign of this game, there are story bosses from the Vulgas like Eterllick, but the Void ...

After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...

Alongside the withdrawal request, the FDA has also placed a clinical hold on all Intercept clinical trials involving obeticholic acid. Intercept Pharmaceuticals has decided to voluntarily withdraw ...

Earlier this month, astronomers noticed a mysterious object speeding toward the inner solar system from outside of our star system. It’s an exceedingly rare occurrence, marking only the third ...